Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Moodys
Merck
Medtronic
Johnson and Johnson

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for IPI-549

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug IPI-549?

IPI-549 is an investigational drug.

There have been 102 clinical trials for IPI-549. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2007.

The most common disease conditions in clinical trials are Lymphoma, Lymphoma, B-Cell, and Lymphoma, Large B-Cell, Diffuse. The leading clinical trial sponsors are Infinity Pharmaceuticals, Inc., Amgen, and Lymphoma Study Association.

Recent Clinical Trials for IPI-549
TitleSponsorPhase
Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota TransplantationAcademic Medical Organization of Southwestern OntarioPhase 1
Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota TransplantationLawson Health Research InstitutePhase 1
Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell CarcinomaThe V Foundation for Cancer ResearchPhase 2

See all IPI-549 clinical trials

Clinical Trial Summary for IPI-549

Top disease conditions for IPI-549
Top clinical trial sponsors for IPI-549

See all IPI-549 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Harvard Business School
Baxter
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.